STK11 and cancer: While individuals without mutations in STK11 exhibit a reduced risk of developing cancer and typically experience a later onset of symptoms, those with the uncommon splicing mutation c.921-1G > C in intron 7 of STK11 face significant health challenges due to its detrimental effects.